# Routine Versus Selective Use of FFR to Guide PCI

Study · id `cardio:ct-nct02000661` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02000661](<https://clinicaltrials.gov/study/NCT02000661>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02000661

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 261 participants.

## Technical summary

Registry record NCT02000661. Randomized; no masking; primary purpose treatment. Start 2014-01 (registry gives no type); primary completion 2017-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 261 participants (enrolled count; ClinicalTrials.gov record NCT02000661, source copy `cardio:ctgov-nct02000661-2019-02-26`, retrieved 2026-10-26)
- Start date: 2014-01 (registry gives no type) (ClinicalTrials.gov record NCT02000661, source copy `cardio:ctgov-nct02000661-2019-02-26`, retrieved 2026-10-26)
- Primary completion: 2017-02 (actual) (ClinicalTrials.gov record NCT02000661, source copy `cardio:ctgov-nct02000661-2019-02-26`, retrieved 2026-10-26)
- Completion: 2017-02 (actual) (ClinicalTrials.gov record NCT02000661, source copy `cardio:ctgov-nct02000661-2019-02-26`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT02000661, source copy `cardio:ctgov-nct02000661-2019-02-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02000661-2019-02-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Routine Versus Selective Use of FFR to Guide PCI
- Acronym: FFR-SELECT
- Condition: Acute Coronary Syndrome
- Condition: Coronary Atherosclerosis
- Condition: Angina, Unstable
- Intervention (Device): Fractional Flow Reserve (FFR)
- Lead sponsor: Cardiology Research UBC
- Lead sponsor class: OTHER
- Collaborator: Provincial Health Services Authority British Columbia
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Unstable angina (`cardio:unstable-angina`)

## Provenance

Content hash: bce72a822cb0a29b992b021d84fd4be0f76515319bc8ddafd1db425a6419f8c2
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
